ClinicalTrials.Veeva

Menu

Balance Effects of Morton´s Extension in Flat Foot

M

Mayuben Private Clinic

Status

Completed

Conditions

Healthy Subjects

Treatments

Other: Morton extension

Study type

Interventional

Funder types

Other

Identifiers

NCT06526715
24/458-E

Details and patient eligibility

About

The aim of this study is to simulate the orthopedic treatment called Morton's extension on flat foot patients to check balance effects in standing position.

Full description

The objective of this study is to perform an assimilation of the orthopedic treatment called morton extension on flat foot patients to verify the balance with stabilometry study.

Enrollment

23 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women and men aged 18 to 30 with flexible flat feet.

Exclusion criteria

  • Participants who have had any previous limb surgery, and/or previous lower limb trauma within the last year
  • Uncorrected hearing or visual impairment.
  • Lumbar pathology with radicular involvement.
  • Pregnancy.
  • Healthy participants performing strenuous exercise.
  • Diagnosed active or inactive rheumatic or inflammatory disease.
  • Participants consuming alcohol within 24 hours prior to recording or stimulants 6 hours prior to testing (e.g. caffeine).
  • Participants who have a history of injury with residual lower extremity symptoms within the past year.
  • Participants with evidence of a leg length discrepancy (difference in distance from the anterior superior iliac spine to the superior iliac spine at the surface of the most prominent aspect of the medial malleolus) of more than 1 cm 19
  • Having at least 15 degrees of ankle dorsiflexion.
  • Participants with evidence of balance deficit, as determined through oral questioning about falls and by use of the Balance Evaluation Systems Test (BESTest).
  • Participants with neurological pathology with lower limb deformities, sensory-motor disturbances, neuromuscular pathology, or neurovascular disease.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

23 participants in 1 patient group

Morton.s extension treatment
Experimental group
Description:
Appliation of Morton´s extension treatment simulation
Treatment:
Other: Morton extension

Trial contacts and locations

1

Loading...

Central trial contact

Eva María Martínez Jiménez, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems